Buy Dr Pepper Snapple (DPS) on Bai Sale Weakness - Stifel
Tweet Send to a Friend
Stifel analyst Mark Swartzberg notes weakness in Dr Pepper Snapple (NYSE: DPS) (-4.1%) is related to news reports that DPS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE